Evidence map›Paper›PMID 41911195›Full record

ArticleRevista de la Facultad de Ciencias Medicas (Cordoba, Argentina)2026

[Performance of prognostic scores during the first and second waves of COVID-19 pneumonia]

Santiago María Tomás Reyna, Melani Zlotogora, María Antonella Correa Barovero, Milagros Wendebourg, Hernán Badariotti, Valentina Cavalli Alessandria, Matías Roggero, Ricardo Venencia, Giuliana Torino, Constanza Cravero and 9 more

Abstract readEnglish Abstract
In one paragraph

Article in Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Santiago María Tomás ReynaHospital Privado Universitario de Córdoba.
Melani ZlotogoraHospital Privado Universitario de Córdoba.
María Antonella Correa BaroveroHospital Privado Universitario de Córdoba.
Milagros WendebourgHospital Privado Universitario de Córdoba.
Hernán BadariottiHospital Privado Universitario de Córdoba.
Valentina Cavalli AlessandriaHospital Privado Universitario de Córdoba.
Matías RoggeroHospital Privado Universitario de Córdoba.
Ricardo VenenciaHospital Privado Universitario de Córdoba.
Giuliana TorinoHospital Privado Universitario de Córdoba.
Constanza CraveroHospital Privado Universitario de Córdoba.
Nicole Marie KahnHospital Privado Universitario de Córdoba.
Paula De LeonardiHospital Privado Universitario de Córdoba.
Silvina Rodríguez BonazziHospital Privado Universitario de Córdoba.
Ayelén TarditiHospital Privado Universitario de Córdoba.
Augusto Douthat BarrionuevoHospital Privado Universitario de Córdoba.
Sofía María VilladaHospital Privado Universitario de Córdoba.
Pehuén FernándezHospital Privado Universitario de Córdoba.
Ricardo Arturo AlbertiniHospital Privado Universitario de Córdoba.
Emanuel José SaadHospital Privado Universitario de Córdoba.ORCID 0000-0001-6244-7607

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Risk stratification in COVID-19 is crucial. We aimed to evaluate and compare the performance of prognostic scores for their respective endpoints (mortality or progression to severity) in hospitalized patients during the first and second pandemic waves in Córdoba, Argentina. Materials and methods: A retrospective cohort study was conducted in a tertiary care hospital. We included adults with COVID-19 pneumonia, comparing outcomes between the first (Mar/2020-Feb/2021) and second wave (Mar/2021-Dec/2021). The discrimination of each score for its specific endpoint (28/30-day mortality or progression) was assessed by ROC analysis. Results: Of 1176 patients, 30-day mortality was lower in the second wave (16.9% vs 28.8%; p<0.001). The 4C Score and PSI/PORT showed the best and most stable discrimination for mortality (AUC ~0.84) across both waves. In patients without initial severe disease, the CALL Score demonstrated acceptable discrimination for predicting progression to severity (AUC 1st wave: 0.71; 2nd wave: 0.67). Conclusion: Prognostic scores for mortality (4C, PSI/PORT) and for progression (CALL Score) maintained their clinical validity across different pandemic waves. They proved to be robust tools for risk stratification according to their respective endpoints, despite changes in patient profiles and vaccination status.

Indexed as

COVID-19AgedArgentinaDisease ProgressionFemaleHumansMaleMiddle AgedPandemicsPrognosisRetrospective StudiesRisk AssessmentROC CurveSARS-CoV-2Severity of Illness Indexcommunity-acquired pneumoniacovid-19hospitalizationpneumoniarisk factors

Identifiers

PMID41911195
PMCPMC13127277

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.